Hims Hers Health is trading at $26.52, down 4.33%, as September inflation exceeded forecasts and revived concerns about interest rates staying higher.
- Reuters reported on October 15 that inflation and rate jitters continued weighing on markets and technology shares.
- Recent securities-class-action deadline notices tied to the earlier FTC lawsuit are also in the news, but no fresh company announcement clearly explains this morning’s decline.
- Healthcare’s reported strength makes a sector-wide explanation less convincing.